Current status and future directions of AI in prostate cancer detection on MRI: a special report from the ESUR prostate MRI working group authors - Report - MDSpire
Clinical Report: The Role of Artificial Intelligence in Prostate Cancer Detection via MRI
Overview
Artificial intelligence (AI) is advancing in prostate MRI. AI systems have demonstrated performance that can equal or surpass that of radiologists in controlled settings, although challenges remain in real-world implementation.
Background
Prostate cancer is a leading cause of cancer mortality among men, making accurate and early diagnosis crucial. The integration of AI into prostate MRI workflows aims to improve diagnostic accuracy and efficiency. However, the clinical deployment of AI tools faces significant challenges, including validation and regulatory compliance.
Data Highlights
Study
AUROC
AI vs Radiologists
False Positives Reduction
Gleason Grade Group 1 Reduction
PI-CAI Study
0.91
6.8% more csPCa detected
50.4% fewer
20.0% fewer
Key Findings
AI systems can automate gland segmentation and enhance PSA density calculations.
Deep learning models have shown DICE scores of 0.90 for whole gland segmentation.
AI detected 6.8% more csPCa compared to the mean performance of 62 radiologists.
AI systems generated 50.4% fewer false-positive findings in csPCa detection.
Zone-aware PSA density can reduce unproductive biopsies by 25% compared to PI-RADS alone.
Clinical Implications
Radiologists must navigate the complexities of AI integration, including understanding algorithmic performance and potential biases.
Conclusion
Further research and validation are necessary to address existing challenges in the integration of AI into prostate MRI.
by Renato Cuocolo, Andrea Ponsiglione, Georgios Agrotis, Tristan Barrett, Giorgio Brembilla, Iztok Caglic, Hanna Falińska, Charlie Alexander Hamm, Emanuele Messina, Tobias Penzkofer, Raphaële Renard-Penna, Olivier Rouvière, Luca Russo, Evis Sala, Johannes Uhlig, Anwar R. Padhani, Maarten de Rooij
